Massachusetts Selecta Biosciences' CEO to Retire at the End of 2018 Post author:Sam Post published:January 1, 2018 Post category:BioPharma Werner Cautreels, Ph.D., intends to retire effective December 31, 2018. Source: BioSpace You Might Also Like Jazz Pharma Bets $175 Million on This Massachusetts Biotech's Antibody-Drug Program August 28, 2017 Spotted in the Bay Area: Former FDA Head in Talks to Join Google's Verily May 16, 2017 Cambrex Corporation Reports Second Quarter 2017 Financial Results August 3, 2017
